References
- . Bodey GP, Chang H, Rodriguez V, Stewart D. Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion. Antimicrob Agents Chemother 8: 328–333, 1975.
- . Stratford BC, Dixson S. Serum levels of gentamicin and tobramycin after slow intravenous bolus injection. Lancet 1: 378–379, 1974.
- . Powell SH, Thompson WL. Once daily vs. continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. J Infect Dis 147: 918–932, 1983.
- . Rubenstein KE, Schneider RS, Ullman EF. Homogenous enzyme immunoassay: A new immunochemical technique. Biochem Biophys Res Commun 47: 846–851, 1972.
- . Konishi H, Goto M, Nakamoto Y, Yamamoto I, Yamashina H. Tobramycin inactivation by carbenicillin, ticarcillin and piperacillin. Antimicrob Agents Chemother 23: 653–657, 1983.
- . Noone P, Beale DF, Pollock SS, Perera MR, Amirak ID, Fernando ON, Moorhead JF. Monitoring aminoglycoside use in patients with severely impaired renal function. Br Med J 2: 470, 1978.
- . Blair DC, Fekety FR, Bruce B, Silva J, Archer G. Therapy of Pseudomonas aeruginosa infections with tobramycin. Antimicrob Agents Chemother 8: 22, 1975.
- . Carmalt ED, Cortez LM, Rosenblatt JE. Clinical experience with tobramycin in the treatment of infections due to gramnegative bacilli. Am J Med Sci 271: 285, 1976.
- . Kahlmeter G, Hallberg TL, Kamme C. Gentamicin and tobramycin in patients with various infections—concentrations in serum and urinary excretion. J Antimicrob Chemother 4, Suppl. A: 37, 1978.
- . Atterholm I, Hedström S-Å, Kahlmeter G, Kamme C. Tobramycin in patients with various infections: A clinical evaluation. Scand J Infect Dis 10: 229–234, 1978.